A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Siva, Shankar ^a   MacManus, Michael ^a,b   Kron, Tomas ^a,b   Best, Nickala ^a   Smith, Jai ^a   Lobachevsky, Pavel ^a,b   Ball, David ^a,b   Martin, Olga ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; EOTAXIN; ETOPOSIDE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 33; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 3; PACLITAXEL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER; CCL11 PROTEIN, HUMAN; CCL2 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; MONOCYTE CHEMOTACTIC PROTEIN 1; TIMP1 PROTEIN, HUMAN;

ADAPTATION; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG TOXICITY; LUNG VOLUME; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIATION DOSE; TREATMENT PLANNING; VERY ELDERLY; ADVERSE EFFECTS; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; GAMMA RADIATION; GENE EXPRESSION; GENETICS; LUNG NEOPLASMS; PATHOLOGY; PNEUMONIA; RADIATION INJURY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL11; CHEMOKINE CCL2; CHEMOKINE CXCL10; FEMALE; GAMMA RAYS; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA; RADIATION INJURIES; RADIOTHERAPY DOSAGE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84907808696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109560     Document Type: Article

References (46)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: A cancer journal for clinicians.
2. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, et al. (2010) Non-small cell lung cancer. Journal of the National Comprehensive Cancer Network 8: 740-801.
3. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee (2004) Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. The Cancer Council Australia and Australian Cancer Network, National Health and Medical Research Council Canberra.
4. Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidencebased clinical guidelines. Cancer 104: 1129-1137.
5. Mauguen A, Le Péchoux C, Saunders MI, Schild SE, Turrisi AT, et al. (2012) Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis. Journal of Clinical Oncology 30: 2788-2797.
6. Fay M, Tan A, Fisher R, MacManus M, Wirth A, et al. (2005) Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. International Journal of Radiation Oncology∗ Biology∗ Physics 61: 1355-1363.
7. Emami B, Lyman J, Brown A, Cola L, Goitein M, et al. (1991) Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology∗ Biology∗ Physics 21: 109-122.
8. Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, et al. (2013) Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 85: 444-450.
9. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, et al. (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for nonsmall cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45: 323-329.
10. Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation; 2007. Elsevier. 81-88.
11. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, et al. (2007) Molecular mechanisms of late normal tissue injury. Elsevier. 121-130.
12. Vujaskovic Z, Marks LB, Anscher MS (2000) The physical parameters and molecular events associated with radiation-induced lung toxicity. Elsevier. 296- 307.
13. Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-smallcell lung cancer: Pulmonary function, prediction, and prevention. International Journal of Radiation Oncology∗ Biology∗ Physics 63: 5-24.
14. Provatopoulou X, Athanasiou E, Gounaris A (2008) Predictive markers of radiation pneumonitis. Anticancer research 28: 2421-2432.
15. McBride WH, Chiang C-S, Olson JL, Wang C-C, Hong J-H, et al. (2004) A Sense of Danger from Radiation 1. Radiation research 162: 1-19.
16. Johnston CJ, Williams JP, Okunieff P, Finkelstein JN (2009) Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families.
17. Thomson AW, Lotze MT (2003) The Cytokine Handbook, Two-Volume Set: Gulf Professional Publishing.
18. Ding N-H, Li JJ, Sun L-Q (2013) Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis. Current drug targets 14: 1247.
19. Talas M, Szolgay E, Varteresz V, Koczkas G (1972) Influence of acute and fractional X-irradiation on induction of interferon in vivo. Arch Gesamte Virusforsch 38: 143-148.
20. Desai S, Kumar A, Laskar S, Pandey B (2013) Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells. Cytokine 61: 54-62.
21. Fu X-L, Huang H, Bentel G, Clough R, Jirtle RL, et al. (2001) Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor b. International Journal of Radiation Oncology∗ Biology∗ Physics 50: 899-908.
22. Anscher MS, Murase T, Prescott DM, Marks LB, Reisenbichler H, et al. (1994) Changes in plasma TGF [beta] levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. International Journal of Radiation Oncology∗ Biology∗ Physics 30: 671-676.
23. Anscher MS, Kong F-M, Andrews K, Clough R, Marks LB, et al. (1998) Plasma transforming growth factor b1 as a predictor of radiation pneumonitis. International Journal of Radiation Oncology∗ Biology∗ Physics 41: 1029-1035.
24. Zhao L, Wang L, Ji W, Wang X, Zhu X, et al. (2009) Elevation of Plasma TGFb1 During Radiation Therapy Predicts Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer: A Combined Analysis From Beijing and Michigan. International Journal of Radiation Oncology∗Biology∗Physics 74: 1385-1390.
25. Arpin D, Perol D, Blay J-Y, Falchero L, Claude L, et al. (2005) Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. Journal of clinical oncology 23: 8748-8756.
26. Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, et al. (2001) Circulating IL-6 as a predictor of radiation pneumonitis. International Journal of Radiation Oncology∗ Biology∗ Physics 49: 641-648.
27. Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, et al. (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy-association of interleukin-8 and VEGF with survival. Cytokine 50: 30-36.
28. Rübe CE, Palm J, Erren M, Fleckenstein J, König J, et al. (2008) Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3: e2898.
29. Zhang M, Yin L, Zhang K, Sun W, Yang S, et al. (2012) Response patterns of cytokines/chemokines in two murine strains after irradiation. Cytokine 58: 169- 177.
30. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A (1997) Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 158: 1033-1036.
31. Conti I, Rollins BJ (2004) CCL2 (monocyte chemoattractant protein-1) and cancer. Elsevier. 149-154.
32. Malik IA, Moriconi F, Sheikh N, Naz N, Khan S, et al. (2010) Single-dose gamma-irradiation induces up-regulation of chemokine gene expression and recruitment of granulocytes into the portal area but not into other regions of rat hepatic tissue. Am J Pathol 176: 1801-1815.
33. Lilly C, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, et al. (1997) Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. Journal of Clinical Investigation 99: 1767.
34. Guo R-F, Lentsch AB, Warner RL, Huber-Lang M, Sarma JV, et al. (2001) Regulatory effects of eotaxin on acute lung inflammatory injury. The Journal of Immunology 166: 5208-5218.
35. Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, et al. (2010) IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 185: 5743-5750.
36. Neta R (1997) Modulation with cytokines of radiation injury: suggested mechanisms of action. Environmental health perspectives 105: 1463.
37. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, et al. (2010) Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 207: 1293-1305.
38. Chen Y, Williams J, Ding I, Hernady E, Liu W, et al. (2002) Radiation pneumonitis and early circulatory cytokine markers. Seminars in Radiation Oncology 12: 26-33.
39. Gallet P, Phulpin B, Merlin J-L, Leroux A, Bravetti P, et al. (2011) Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring. PloS one 6: e29399.
40. Naito Y, Yoshikawa T (2005) Role of matrix metalloproteinases in inflammatory bowel disease. Molecular aspects of medicine 26: 379-390.
41. Feng M, Kong F-M, Gross M, Fernando S, Hayman JA, et al. (2009) Using Fluorodeoxyglucose Positron Emission Tomography to Assess Tumor Volume During Radiotherapy for Non-Small-Cell Lung Cancer and Its Potential Impact on Adaptive Dose Escalation and Normal Tissue Sparing. International Journal of Radiation Oncology∗ Biology∗ Physics 73: 1228-1234.
42. Rübe CE, Wilfert F, Palm J, König J, Burdak-Rothkamm S, et al. (2004) Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. Strahlentherapie und Onkologie 180: 442-448.
43. Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, et al. (2011) New insights into the molecular pathology of radiation-induced pneumopathy. Radiotherapy and Oncology 101: 86-92.
44. Ao X, Zhao L, Davis MA, Lubman DM, Lawrence TS, et al. (2009) Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol 2.
45. Johnston CJ, Wright TW, Rubin P, Finkelstein JN (1998) Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and-sensitive mice after thoracic irradiation. Experimental lung research 24: 321-337.
46. Anscher MS, Kong F-M, Marks LB, Bentel GC, Jirtle RL (1997) Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. International Journal of Radiation Oncology∗ Biology∗ Physics 37: 253-258.